78% of men survive myeloma for at least one year, and this is predicted to fall to 50% surviving for five years or more, as shown by
Myeloma (C90), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 2010-2011
|1-Year Survival (%)||5-Year Survival (%)||10-Year Survival (%)|
95% LCL and 95% UCL are the 95% lower and upper
Five- and ten-year survival is predicted using an excess hazard statistical model
Myeloma survival continues to fall beyond five years after diagnosis. 37% of men and 28% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with myeloma during 2010-2011 in England and Wales. Out of 20 common cancers in England and Wales, ten-year survival for myeloma ranks 6th lowest overall.
Myeloma (C90), Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales, 2010-2011
Survival for myeloma is reported in Scotland and Northern Ireland,[2,3] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses. An analysis of patients diagnosed with myeloma during 1991-1999 suggests all four UK countries have similar survival.
- Data were provided by London School of Hygiene and Tropical Medicine on request, 2014.
- ISD Scotland. Trends in Cancer Survival 1983-2007.
- Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.
- Woods LM, Rachet B, Shack L, et al. Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth century. Health Stat Q 2010;(46):5-24.
About this data
Data is for: England and Wales, 2010-2011, ICD-10 C90